Related references
Note: Only part of the references are listed.Comparison of estrogen receptor, progesterone receptor and Her-2 status in breast cancer pre- and post-neoadjuvant chemotherapy
Masako Kasami et al.
BREAST (2008)
The effect of neoadjuvant chemotherapy on histologic grade, hormone receptor status, and Her2/neu status in breast carcinoma
Amy L. Adams et al.
BREAST JOURNAL (2008)
Changes in the tumor grade and biological markers in locally advanced breast cancer after chemotherapy - Implications for a pathologist
Tanuja Shet et al.
BREAST JOURNAL (2007)
Changes in and prognostic value of hormone receptor status in a series of operable breast cancer patients treated with neoadjuvant chemotherapy
Olivier Tacca et al.
ONCOLOGIST (2007)
HER2/neu, p53, Ki67, and hormone receptors do not change during neoadjuvant chemotherapy in breast cancer
N Arens et al.
VIRCHOWS ARCHIV (2005)
Evaluation of ER, PgR, HER-2 and Ki-67 as predictors of response to neoadjuvant anthracycline chemotherapy for operable breast cancer
RJ Burcombe et al.
BRITISH JOURNAL OF CANCER (2005)
Chemotherapy is more effective in patients with breast cancer not expressing steroid hormone receptors:: A study of preoperative treatment
M Colleoni et al.
CLINICAL CANCER RESEARCH (2004)
The effect of neoadjuvant chemotherapy on estrogen and progesterone receptor expression and hormone receptor status in breast cancer
SH Lee et al.
AMERICAN JOURNAL OF SURGERY (2003)
International expert panel on the use of primary (Preoperative) systemic treatment of operable breast cancer: Review and recommendations
M Kaufmann et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Sequential steroid hormone receptor measurements in primary breast cancer with and without intervening primary chemotherapy
S Taucher et al.
ENDOCRINE-RELATED CANCER (2003)
Share Paper
